142 related articles for article (PubMed ID: 15846142)
21. Analysis of dendritic cells in sentinel lymph nodes of patients with endometrial and patients with cervical cancers.
Kara PP; Ayhan A; Caner B; Gultekin M; Ugur O; Bozkurt MF; Usubutun A; Uner A
Int J Gynecol Cancer; 2009 Oct; 19(7):1239-43. PubMed ID: 19823061
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
[TBL] [Abstract][Full Text] [Related]
24. Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome.
Mohos A; Sebestyén T; Liszkay G; Plótár V; Horváth S; Gaudi I; Ladányi A
J Transl Med; 2013 Feb; 11():43. PubMed ID: 23418928
[TBL] [Abstract][Full Text] [Related]
25. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
26. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy.
Li LX; Scolyer RA; Ka VS; McKinnon JG; Shaw HM; McCarthy SW; Thompson JF
Am J Surg Pathol; 2003 Sep; 27(9):1197-202. PubMed ID: 12960803
[TBL] [Abstract][Full Text] [Related]
27. Idiosyncrasies of scalp melanoma.
Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
[TBL] [Abstract][Full Text] [Related]
28. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.
Poindexter NJ; Sahin A; Hunt KK; Grimm EA
Breast Cancer Res; 2004; 6(4):R408-15. PubMed ID: 15217509
[TBL] [Abstract][Full Text] [Related]
29. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas.
Vermi W; Bonecchi R; Facchetti F; Bianchi D; Sozzani S; Festa S; Berenzi A; Cella M; Colonna M
J Pathol; 2003 Jun; 200(2):255-68. PubMed ID: 12754747
[TBL] [Abstract][Full Text] [Related]
30. Molecular analyses of sentinel lymph nodes: an open question.
Bonin S; Niccolini B; Calacione R; Gambardella B; Geatti O; Stanta G; Trevisan G
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):34-9. PubMed ID: 11952287
[TBL] [Abstract][Full Text] [Related]
31. The development of optimal pathological assessment of sentinel lymph nodes for melanoma.
Cook MG; Green MA; Anderson B; Eggermont AM; Ruiter DJ; Spatz A; Kissin MW; Powell BW;
J Pathol; 2003 Jul; 200(3):314-9. PubMed ID: 12845627
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.
Takeuchi H; Taback B; Kuo C; Hoon DS
Ann Surg Oncol; 2004 Mar; 11(3 Suppl):152S-5S. PubMed ID: 15023743
[TBL] [Abstract][Full Text] [Related]
33. Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients.
Nicholl MB; Elashoff D; Takeuchi H; Morton DL; Hoon DS
Ann Surg; 2011 Jan; 253(1):116-22. PubMed ID: 21135695
[TBL] [Abstract][Full Text] [Related]
34. Sentinel node biopsy in melanoma.
Hauschild A; Christophers E
Virchows Arch; 2001 Feb; 438(2):99-106. PubMed ID: 11253124
[TBL] [Abstract][Full Text] [Related]
35. Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes.
Goydos JS; Patel KN; Shih WJ; Lu SE; Yudd AP; Kempf JS; Bancila E; Germino FJ
J Am Coll Surg; 2003 Feb; 196(2):196-204; discussion 204-5. PubMed ID: 12595045
[TBL] [Abstract][Full Text] [Related]
36. Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation.
Sluijter BJ; van den Hout MF; Koster BD; van Leeuwen PA; Schneiders FL; van de Ven R; Molenkamp BG; Vosslamber S; Verweij CL; van den Tol MP; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Cancer Immunol Res; 2015 May; 3(5):495-505. PubMed ID: 25633713
[TBL] [Abstract][Full Text] [Related]
37. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens.
Ciotti P; Rainero ML; Nicolò G; Spina B; Garrè C; Casabona F; Santi PL; Bianchi-Scarrà G
Melanoma Res; 1995 Feb; 5(1):41-7. PubMed ID: 7734955
[TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Slingluff CL; Petroni GR; Yamshchikov GV; Barnd DL; Eastham S; Galavotti H; Patterson JW; Deacon DH; Hibbitts S; Teates D; Neese PY; Grosh WW; Chianese-Bullock KA; Woodson EM; Wiernasz CJ; Merrill P; Gibson J; Ross M; Engelhard VH
J Clin Oncol; 2003 Nov; 21(21):4016-26. PubMed ID: 14581425
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.
Reintgen M; Murray L; Akman K; Giuliano R; Lozicki A; Shivers S; Reintgen D
Ann Surg Oncol; 2013 Feb; 20(2):668-74. PubMed ID: 23054112
[TBL] [Abstract][Full Text] [Related]
40. Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.
Straten Pt; Dahl C; Schrama D; Pedersen LØ; Andersen MH; Seremet T; Bröcker EB; Guldberg P; Becker JC
Cancer Immunol Immunother; 2006 May; 55(5):495-502. PubMed ID: 16001163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
